Cite
Calcium-activated-calcineurin reduces the In vitro and In vivo sensitivity of fluconazole to Candida albicans via Rta2p.
MLA
Yu Jia, et al. “Calcium-Activated-Calcineurin Reduces the In Vitro and In Vivo Sensitivity of Fluconazole to Candida Albicans via Rta2p.” PLoS ONE, vol. 7, no. 10, Jan. 2012, p. e48369. EBSCOhost, https://doi.org/10.1371/journal.pone.0048369.
APA
Yu Jia, Ren-Jie Tang, Lin Wang, Xiang Zhang, Ying Wang, Xin-Ming Jia, & Yuan-Ying Jiang. (2012). Calcium-activated-calcineurin reduces the In vitro and In vivo sensitivity of fluconazole to Candida albicans via Rta2p. PLoS ONE, 7(10), e48369. https://doi.org/10.1371/journal.pone.0048369
Chicago
Yu Jia, Ren-Jie Tang, Lin Wang, Xiang Zhang, Ying Wang, Xin-Ming Jia, and Yuan-Ying Jiang. 2012. “Calcium-Activated-Calcineurin Reduces the In Vitro and In Vivo Sensitivity of Fluconazole to Candida Albicans via Rta2p.” PLoS ONE 7 (10): e48369. doi:10.1371/journal.pone.0048369.